Visualizaciones | |
---|---|
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial | 78 |
octubre 2023 | noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | |
---|---|---|---|---|---|---|---|
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial | 1 | 0 | 0 | 2 | 2 | 6 | 1 |
Visualizaciones |
---|
Visualizaciones |
---|